UPDATE TO SHAREHOLDERS REGARDING ACTIONS TAKEN BY THE COMPANY AGAINST THE  UMUTHI ACTION GROUP ("UAG") AND ANTHONY MORRIS ("MORRIS") On Friday 28 October 2022, the Financial Conduct Authority ("FCA") published the contents of the First Supervisory Notice ("FSN") issued to the Company originally dated 4th July 2022. The...

UPDATE TO SHAREHOLDERS REGARDING THE PUBLICATION  BY THE  FINANCIAL CONDUCT AUTHORITY ("FCA") ON 28 OCTOBER 2022 OF THE FSN DATED 4 JULY 2022 Following the  publication by the FCA on Friday 28 October 2022, of  the First Supervisory Notice ("FSN") issued to the Company dated 4th July...

...

...

The Company announces an update on certain corporate matters. The Company issued a Supplementary Prospectus on 26 February 2021, which contained historical financial information for the periods ended 8 February 2019 and 28 February 2020 for Umuthi, and its wholly owned operating subsidiary, Lems Pharmaceutical Limited...

The Company is pleased to announce the appointment of Jeffreys Henry LLP as its new auditors with immediate effect. Jeffreys Henry LLP replace PKF Littlejohn who formally resigned on 10 March 2021 and confirmed that there are no reasons or matters connected with their ceasing to...

Umuthi Healthcare Solutions Plc, the technology led healthcare business focused on the distribution of pharmaceuticals and the provision of medical facilities in remote areas, is pleased to announce the admission of its shares to the Official List (by way of a Standard Listing under Chapter...

Umuthi Healthcare Solutions Plc, the technology led healthcare business focused on the distribution of pharmaceuticals and the provision of medical facilities in remote areas, is pleased to announce today its intention to seek admission to the Standard Listing segment of the Official List of the FCA...